Start for free
Start for free
Hatteras Venture Partners logo

Hatteras Venture Partners

North America, North Carolina, United States, Durham

Description

Hatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.

Investor Profile

Hatteras Venture Partners has made 117 investments, with 7 in the past 12 months and 37% as lead.

Stage Focus

  • Series A (39%)
  • Series B (25%)
  • Series Unknown (14%)
  • Series C (11%)
  • Seed (6%)
  • Series D (2%)
  • Private Equity (2%)
  • Series E (1%)
  • Convertible Note (1%)

Country Focus

  • United States (95%)
  • Canada (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
  • Software
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hatteras Venture Partners frequently co-invest with?

Mountain Group Capital
Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 12
Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 6
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 13
Excelerate Health Ventures
Excelerate Health Ventures
North America, North Carolina, United States, Durham
Co-Investments: 8
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 8
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 7
Lilly Ventures
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 5
Sanofi Ventures
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Fletcher Spaght, Inc.
Fletcher Spaght, Inc.
North America, Massachusetts, United States, Boston
Co-Investments: 7

Which angels does Hatteras Venture Partners often collaborate with?

RD
Rick Deckelbaum
North America, North Carolina, United States, Raleigh
Shared Deals: 1
MB
Marc Benioff
North America, California, United States, San Francisco
Shared Deals: 1
IK
Idan Koren
North America, California, United States
Shared Deals: 1
HJ
Howard Jacobson
North America, New York, United States, New York
Shared Deals: 1
BJ
Barrett Joyner
North America, North Carolina, United States, Raleigh
Shared Deals: 1
GM
George McLendon
North America, Texas, United States, Houston
Shared Deals: 1
MB
Michael Brader Araje
North America, North Carolina, United States, Durham
Shared Deals: 1
AP
Andrew Pecora
North America, New Jersey, United States, Hackensack
Shared Deals: 1
BK
Brian Kinnahan
North America, California, United States, Los Angeles
Shared Deals: 1
TB
Timothy Buckley
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Hatteras Venture Partners?

410 Medical

Durham, North Carolina, United States

410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care.

Health CareMedicalMedical Device
Series BMar 17, 2025
Amount Raised: $14,000,000
BEKHealth

Branford, Connecticut, United States

BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to optimize clinical research enrollment.

Clinical TrialsHospitalInformation ServicesMedicalMedical DevicePharmaceutical
Series UnknownFeb 13, 2025
Amount Raised: $4,000,000
Synaptrix

Alpharetta, Georgia, United States

Synaptrix is a healthcare company that offers medical products for postoperative pain treatment.

Health CareMedicalWellness
Series ANov 15, 2024
Amount Raised: $10,000,000
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
Endogenex

Plymouth, Minnesota, United States

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Health CareMedical DeviceTherapeutics
Series CJun 25, 2024
Amount Raised: $88,000,000
AtaCor Medical

San Clemente, California, United States

AtaCor Medical is a medical device maker.

Health CareMedical Device
Series CApr 24, 2024
Amount Raised: $28,000,000
iVEAcare

Minneapolis, Minnesota, United States

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

Health CareMedical Device
Series AApr 22, 2024
Amount Raised: $27,500,000
Veralox Therapeutics

Frederick, Maryland, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownJun 20, 2023
Amount Raised: $24,000,000
410 Medical

Durham, North Carolina, United States

410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care.

Health CareMedicalMedical Device
Series BMay 25, 2023
Amount Raised: $7,500,000
Myeloid Therapeutics

Cambridge, Massachusetts, United States

Myeloid Therapeutics is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.

BiotechnologyLife ScienceTherapeutics
Series AMay 18, 2023
Amount Raised: $73,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator